NYSE · Financial Statements

Cardinal Health, Inc. (CAH) Financial Statements

$249.57 NYSE: CAH Market Cap $57.79B

Cardinal Health, Inc. most recently reported annual revenue of $254.2B, net profit of $1.7B. Revenue grew at an average annual rate of 9.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Cardinal Health, Inc.: Revenue rose from $130.0B in 2017 to $254.2B in 2026, a change of +95.6% over 9 years; net profit was positive in 8 of 10 reported years; operating margin moved from 1.6% to 1.0%, a shift of -0.6 percentage points; the most recent year shows net profit of $1.7B.

Income Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Revenue$130.0B$136.8B$145.5B$152.9B$162.5B$181.3B$205.0B$226.8B$222.6B$254.2B
Operating Expenses$127.9B$136.7B$143.5B$157.0B$162.0B$181.9B$204.2B$225.6B$220.3B$251.6B
Operating Profit$2.1B$126.0M$2.1B$-4.1B$472.0M$-607.0M$752.0M$1.2B$2.3B$2.6B
Operating Margin1.6%0.1%1.4%-2.7%0.3%-0.3%0.4%0.6%1.0%1.0%
Other Income$-196.0M$-354.0M$-309.0M$326.0M$-149.0M$-177.0M$-89.0M$-42.0M$-174.0M$-439.0M
Interest$201.0M$329.0M$294.0M$238.0M$180.0M$147.0M$84.0M$51.0M$215.0M$348.0M
Depreciation$717.0M$1.0B$1.0B$913.0M$783.0M$692.0M$692.0M$710.0M$790.0M$956.0M
Profit Before Tax$1.9B$-228.0M$1.8B$-3.8B$323.0M$-784.0M$663.0M$1.2B$2.1B$2.2B
Tax$32.7M$213.6M$22.0M$2.1M$-89.5M$-19.5M$50.1M$29.0M$25.3M$21.6M
Net Profit$1.3B$256.0M$1.4B$-3.7B$611.0M$-938.0M$330.0M$852.0M$1.6B$1.7B
EPS$4.03$0.81$4.53$-12.60$2.08$-3.34$1.26$3.45$6.45$7.23
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$54.6B$57.4B$54.9B$59.7B$52.3B$55.3B$54.9B$60.2B$64.0B$65.4B$60.9B$63.9B
Operating Expenses$54.7B$56.9B$54.5B$59.3B$51.7B$54.7B$54.1B$59.7B$63.3B$64.7B$60.4B$63.1B
Operating Profit$-32.0M$505.0M$369.0M$408.0M$568.0M$549.0M$730.0M$428.0M$668.0M$707.0M$509.0M$729.0M
Operating Margin-0.1%0.9%0.7%0.7%1.1%1.0%1.3%0.7%1.0%1.1%0.8%1.1%
Interest$11.0M$3.0M$28.0M$4.0M$32.0M$35.0M$74.0M$74.0M$80.0M$88.0M$101.0M$79.0M
Profit Before Tax$-44.0M$512.0M$342.0M$396.0M$541.0M$511.0M$665.0M$384.0M$598.0M$630.0M$392.0M$554.0M
Tax$75.0M$27.9M$23.4M$40.9M$22.9M$21.5M$23.6M$36.7M$24.1M$25.2M$3.1M$27.8M
Net Profit$-12.0M$368.0M$261.0M$236.0M$416.0M$400.0M$506.0M$239.0M$450.0M$471.0M$399.0M$394.0M
EPS$-0.05$1.50$1.07$0.96$1.70$1.65$2.10$1.00$1.88$1.97$1.69$1.69

Over the 10 years reported for Cardinal Health, Inc., borrowings decreased from $10.4B in 2017 to $9.9B in 2026, cash stood at $4.9B in the latest year, shareholders' equity was $2.9B, current assets covered current liabilities 0.88 times.

Balance Sheet — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Total Assets$40.1B$40.0B$41.0B$40.8B$44.5B$43.9B$43.3B$45.1B$53.1B$57.3B
Current Assets$28.3B$24.6B$25.7B$25.9B$31.0B$32.9B$33.7B$34.9B$36.4B$38.8B
Cash$6.9B$1.8B$2.5B$2.8B$3.4B$4.7B$4.1B$5.1B$3.9B$4.9B
Inventory$11.3B$12.3B$12.8B$13.2B$14.6B$15.6B$16.1B$15.0B$16.8B$17.3B
Receivables$8.0B$7.8B$8.4B$8.3B$9.1B$10.6B$11.1B$12.1B$13.2B$13.8B
Fixed Assets$1.9B$2.5B$2.4B$2.4B$2.4B$2.4B$2.5B$2.5B$2.9B$4.0B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$68.0M$77.0M$56.0M$43.0M$14.0M$0
Other Assets$7.2B$8.3B$8.4B$8.4B$8.0B$5.9B$4.6B$4.7B$9.7B$11.4B
Total Liabilities$33.3B$33.9B$34.6B$39.0B$42.7B$44.6B$46.3B$48.3B$55.8B$60.0B
Current Liabilities$21.2B$22.9B$24.1B$23.6B$27.6B$30.6B$33.7B$35.6B$38.9B$43.9B
Borrowings$10.4B$9.0B$8.0B$6.8B$6.7B$5.8B$5.2B$5.6B$9.3B$9.9B
Other Liabilities$22.9B$24.9B$26.6B$32.2B$35.9B$38.8B$41.1B$42.7B$46.4B$50.1B
Equity$2.7B$2.7B$2.8B$2.8B$2.8B$2.8B$2.7B$2.9B$3.0B$2.9B
Reserves$6.8B$6.1B$6.3B$1.8B$1.8B$-709.0M$-3.0B$-3.2B$-2.8B$-2.9B

For Cardinal Health, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $4.5B; free cash flow was positive in 10 of 10 years; financing activities used $1.4B in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Operating Cash Flow$1.2B$2.8B$2.7B$2.0B$2.4B$3.1B$2.8B$3.8B$2.4B$5.2B
Investing Cash Flow$-792.0M$-6.0B$10.0M$118.0M$-778.0M$180.0M$-935.0M$-2.4B$-6.2B$-3.2B
Financing Cash Flow$-541.0M$-694.0M$-614.0M$-230.0M$-174.0M$-1.0B$-1.9B$-704.0M$-778.0M$-1.4B
Net Cash Flow$4.5B$-5.1B$768.0M$240.0M$636.0M$1.3B$-669.0M$1.1B$-1.3B$982.0M
Free Cash Flow$797.0M$2.4B$2.4B$1.6B$2.0B$2.7B$2.4B$3.3B$1.9B$4.5B

Valuation & Return Ratios

MetricValue
PEG Ratio2.86
EV / EBITDA18.61
FCF Yield7.59%
Quick Ratio0.49
Interest Coverage7.51
Return 1Y58.29%
Return 3Y178.86%
Return 5Y481.16%

Cardinal Health, Inc. (CAH) financials — frequently asked questions

What is Cardinal Health, Inc.'s annual revenue?

Cardinal Health, Inc. (CAH) reported annual revenue of $254.2B in its most recent fiscal year.

What is Cardinal Health, Inc.'s net profit?

Cardinal Health, Inc. (CAH) reported net profit of $1.7B in its most recent fiscal year.

What is CAH EV/EBITDA?

Cardinal Health, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 18.61.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
CAH Overview CAH Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.